Fayez Sarofim & Co’s GE HealthCare GEHC Stock Holding History

Fayez Sarofim & Co’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$545K	Hold	7,650	–	–	﹤0.01%	217
2025 Q4	$627K	Hold	7,650	–	–	﹤0.01%	207
2025 Q3	$575K	Sell	7,650 -250	-3%	-$18.6K	﹤0.01%	220
2025 Q2	$585K	Sell	7,900 -89	-1%	-$6.2K	﹤0.01%	217
2025 Q1	$645K	Sell	7,989 -1,161	-13%	-$99.8K	﹤0.01%	211
2024 Q4	$715K	Buy	9,150 +625	+7%	+$53.1K	﹤0.01%	211
2024 Q3	$800K	Sell	8,525 -50	-0.6%	-$4.2K	﹤0.01%	187
2024 Q2	$668K	Sell	8,575 -25	-0.3%	-$2.04K	﹤0.01%	196
2024 Q1	$782K	Sell	8,600 -250	-3%	-$20.8K	﹤0.01%	182
2023 Q4	$720K	Buy	8,850 +3,080	+53%	+$216K	﹤0.01%	186
2023 Q3	$393K	Buy	5,770 +275	+5%	+$20K	﹤0.01%	230
2023 Q2	$446K	Buy	5,495 +117	+2%	+$9.34K	﹤0.01%	217
2023 Q1	$441K	Buy	+5,378	New	+$384K	﹤0.01%	224

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fayez Sarofim & Co's GEHC Position: Q1 2026 in Review

Fayez Sarofim & Co held its GE HealthCare (GEHC) position steady in Q1 2026 at 7,650 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #217.

Fayez Sarofim & Co first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $800K in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Fayez Sarofim & Co held 7,650 shares of GE HealthCare worth $545K as of Q1 2026.
Fayez Sarofim & Co left its GE HealthCare share count unchanged in Q1 2026.
GE HealthCare made up ﹤0.01% of Fayez Sarofim & Co's portfolio in Q1 2026, its #217 holding.
Fayez Sarofim & Co first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
Fayez Sarofim & Co's GE HealthCare position peaked at $800K in Q3 2024.
1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.